LOQUS23 THERAPEUTICS LIMITED
LOQUS23 THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 11914774, incorporated on 29 March 2019. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 7 years. Registered office address: CB21 6GP Great Abington, the United Kingdom. Directors include DR CHRISTIAN BILLY JUNG, DR CYRUS MOZAYENI, and DR FLORIAN MUELLERSHAUSEN, and 2 others. Shareholders include DEMENTIA DISCOVERY GP LP and DDF PARALLEL LLP. Associated with 4 related entities, including DDF PARALLEL LLP, NRG THERAPEUTICS LTD, and AMPHISTA THERAPEUTICS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
SUITE 7 MCCLINTOCK BUILDING
GRANTA PARK
CAMBRIDGESHIRE
CB21 6GP GREAT ABINGTON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 11914774 | 2026-06-01 | open_in_new |